Usana Health Sciences, Inc. balance sheet USNA

Annual Quarterly

As of Jul 4, 2026, Usana Health Sciences, Inc. had total assets of $703.2 million and total liabilities of $132.2 million. Total assets were down 4.3% from a year earlier. Stockholders' equity was $526.3 million. Cash and investments were $168.6 million. The current ratio, current assets divided by current liabilities, was 2.66.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Line	Q2 FY2026 Jul 4, 2026	Q1 FY2026 Apr 4, 2026	Q4 FY2025 Jan 3, 2026	Q3 FY2025 Sep 27, 2025	Q2 FY2025 Jun 28, 2025	Q1 FY2025 Mar 29, 2025	Q4 FY2023 Dec 28, 2024	Q3 FY2024 Sep 28, 2024
Assets
Cash	169 +11.4%	163 -9.4%	158	145 -60.2%	151 -54.5%	180 -45.3%	182 -24.2%	365 +18.8%
Cash and investments	169 +11.4%	163 -9.4%	158	145 -60.2%	151 -54.5%	180 -45.3%	182 -24.2%	365 +18.8%
Receivables	3	10	—	—	—	—	—	—
Inventory	86 +3.7%	96 +31.0%	103	91 +41.9%	83 +34.7%	74 +20.8%	70 -29.1%	64 +6.5%
Total current assets	281 +7.3%	294 +4.6%	288	264 -41.5%	262 -37.5%	281 -33.2%	279 -23.5%	451 +15.6%
Property and equipment, net	94 -2.3%	95 +0.4%	94	96 -1.9%	97 -1.2%	94 -4.0%	95 -7.1%	98 +3.0%
Goodwill	109 -24.3%	138 -4.2%	138	144 +739.1%	144 +756.6%	144 +753.3%	144 +716.0%	17 +2.4%
Total assets	703 -4.3%	739 -1.0%	743	727 +8.2%	735 +16.3%	747 +18.6%	748 +29.5%	671 +11.7%
Liabilities and equity
Accounts payable	15 -13.8%	16 +16.1%	17	16 +130.4%	18 +169.2%	14 +69.1%	12 -11.3%	7 -24.5%
Total current liabilities	106 -13.1%	117 -14.7%	129	119 +3.4%	122 +17.1%	137 +22.0%	140 -13.2%	115 +2.0%
Total liabilities	132 -11.2%	144 -11.4%	157	145	149	163	162	—
Stockholders' equity	526 -0.9%	544 +2.6%	533	528 -0.9%	531 +3.7%	530 +6.0%	532 +34.7%	533 +13.3%
Debt
Lease liabilities	—	—	18	—	—	—	16 -6.3%	—
Total debt	—	—	18	—	—	—	16 -6.3%	—
Net cash	—	—	140	—	—	—	166 -25.6%	—
Ratios
Current ratio	2.66x	2.51x	2.24x	2.23x	2.15x	2.05x	2.00x	3.93x
Debt to equity	—	—	0.03x	—	—	—	0.03x	—
Debt to EBITDA	—	—	0.26x	—	—	—	0.15x	—
Return on equity	-4.21%	1.63%	2.02%	—	—	—	11.99%	10.19%
Return on assets	-3.15%	1.20%	1.45%	—	—	—	8.53%	8.09%
Book value per share	28.51	29.45	29.16	28.90	29.08	28.20	27.91	27.97

How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry: Medicinal Chemicals & Botanical Products (SIC 2833)
Listed as: USNA (NYSE)
Fiscal year ends: January 3
Incorporated in: UT
Headquarters: Salt Lake City, UT
SEC filer status: Accelerated filer
SEC CIK: 896264
Former names: USANA INC (until Apr 27, 2000)

Other Medicinal Chemicals & Botanical Products companies

All 43 Medicinal Chemicals & Botanical Products companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.